New Key Statistics Module, Z-Score and F-Score
OTCPK:GGNNQ Key Ratios
| Market Cap $ M | -- |
| Enterprise Value $ M | -- |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -- |
| Beneish M-Score | -3.33 |
| 10-y EBITDA Growth Rate % | 27.00 |
| 5-y EBITDA Growth Rate % | 52.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.13 |
| EV-to-EBITDA | 0.13 |
| PEG | -- |
| Shares Outstanding M | -- |
| Net Margin (%) | -1,946.15 |
| Operating Margin % | -2,901.31 |
| Pre-tax Margin (%) | -1,946.15 |
| Quick Ratio | 1.35 |
| Current Ratio | 1.35 |
| ROA % (ttm) | -57.93 |
| ROE % (ttm) | -223.76 |
| ROIC % (ttm) | -241.51 |
| Dividend Yield % | -- |
| Altman Z-Score | -18.12 |
GGNNQ Number of Guru Trades
GGNNQ Volume of Guru Trades
Gurus Latest Trades with OTCPK:GGNNQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:GGNNQ is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Genocea Biosciences Inc Insider Transactions
No Available Data
News about OTCPK:GGNNQ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers